GBT logo

GBT Cash From Operations

Annual CFO

-$256.81 M
-$44.95 M-21.22%

December 31, 2021

Summary

Performance

1-Year Change

-21.22%

3-Year Change

-89.7%

5-Year Change

-176.08%

15-Year Change

-176.08%

GBT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$14.70 M

3-Year Low

-$256.81 M
GBT annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
GBT previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
GBT next annual earnings announcement has not yet been scheduled

OtherGBTcash flowmetrics:

Annual CFI

$12.11 M
GBT annual cash flow from investing activities is $12.11 million

Annual CFF

$434.33 M
GBT annual cash flow from financing activities is $434.33 million

Annual FCF

-$260.05 M
GBT annual free cash flow is -$260.05 million

Annual CAPEX

$3.23 M
GBT annual capital expenditures is $3.23 million

Quarterly CFO

-$44.31 M
+$27.55 M+38.34%

June 30, 2022

Summary

Performance

3-Month Change

+38.34%

1-Year Change

+0.03%

3-Year Change

-16.79%

5-Year Change

-127.48%

GBT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$4.28 M

3-Year Low

-$71.85 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
GBT previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
GBT next earnings announcement has not yet been scheduled

OtherGBTcash flowmetrics:

Quarterly CFI

-$134.66 M
GBT quarterly cash flow from investing activities is -$134.66 million

Quarterly CFF

$48.60 M
GBT quarterly cash flow from financing activities is $48.60 million

Quarterly FCF

-$44.69 M
GBT quarterly free cash flow is -$44.69 million

Quarterly CAPEX

$384.00 K
GBT quarterly capital expenditures is $384.00 thousand

TTM CFO

-$249.40 M
+$13.00 K+0.01%

June 30, 2022

Summary

Performance

3-Month Change

+0.01%

1-Year Change

-19.14%

3-Year Change

-28.28%

5-Year Change

-28.28%

GBT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$4.28 M

3-Year Low

-$256.81 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
GBT previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
GBT next earnings announcement has not yet been scheduled

OtherGBTcash flowmetrics:

TTM CFI

-$390.80 M
GBT TTM cash flow from investing activities is -$390.80 million

TTM CFF

$482.46 M
GBT TTM cash flow from financing activities is $482.46 million

TTM FCF

-$251.35 M
GBT TTM free cash flow is -$251.35 million

TTM CAPEX

$1.95 M
GBT TTM capital expenditures is $1.95 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

GBT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-21.2%+0.0%-19.1%
3 y3 years-89.7%-16.8%-28.3%
5 y5 years-176.1%-127.5%-28.3%

GBT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+62.2%at high+3.0%
5 y5-year+32.1%at low+8.9%+78.9%+28.3%+3.0%
alltimeall time+1647.0%at low+935.7%+78.9%+5729.8%+3.0%

Global Blood Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2022
-
-$44.31 M(-38.3%)
-$249.40 M(-0.0%)
Mar 2022
-
-$71.85 M(+5.8%)
-$249.41 M(-2.9%)
Dec 2021
-$256.81 M(+21.2%)
-$67.93 M(+4.0%)
-$256.81 M(+9.8%)
Sep 2021
-
-$65.31 M(+47.4%)
-$233.95 M(+11.8%)
Jun 2021
-
-$44.32 M(-44.1%)
-$209.34 M(-1.5%)
Mar 2021
-
-$79.26 M(+75.9%)
-$212.50 M(+0.3%)
Dec 2020
-$211.86 M(+9.0%)
-$45.07 M(+10.7%)
-$211.86 M(-7.5%)
Sep 2020
-
-$40.69 M(-14.3%)
-$229.13 M(-5.4%)
Jun 2020
-
-$47.48 M(-39.6%)
-$242.27 M(+4.1%)
Mar 2020
-
-$78.62 M(+26.1%)
-$232.72 M(+19.7%)
Dec 2019
-$194.42 M(+43.6%)
-$62.34 M(+15.8%)
-$194.42 M(+17.4%)
Sep 2019
-
-$53.83 M(+41.9%)
-$165.65 M(+16.1%)
Jun 2019
-
-$37.94 M(-5.9%)
-$142.73 M(+2.7%)
Mar 2019
-
-$40.32 M(+20.1%)
-$138.93 M(+2.6%)
Dec 2018
-$135.38 M
-$33.57 M(+8.6%)
-$135.38 M(+6.5%)
Sep 2018
-
-$30.90 M(-9.5%)
-$127.16 M(+4.3%)
Jun 2018
-
-$34.13 M(-7.2%)
-$121.87 M(+13.7%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$36.77 M(+45.0%)
-$107.21 M(+15.3%)
Dec 2017
-$93.02 M(+37.4%)
-$25.36 M(-1.0%)
-$93.02 M(+6.0%)
Sep 2017
-
-$25.61 M(+31.5%)
-$87.72 M(+8.4%)
Jun 2017
-
-$19.48 M(-13.7%)
-$80.91 M(+6.9%)
Mar 2017
-
-$22.57 M(+12.6%)
-$75.66 M(+11.7%)
Dec 2016
-$67.72 M(+119.2%)
-$20.05 M(+6.6%)
-$67.72 M(+18.2%)
Sep 2016
-
-$18.81 M(+32.2%)
-$57.32 M(+21.1%)
Jun 2016
-
-$14.23 M(-2.8%)
-$47.35 M(+20.0%)
Mar 2016
-
-$14.63 M(+51.7%)
-$39.46 M(+27.8%)
Dec 2015
-$30.89 M(+53.5%)
-$9.65 M(+9.1%)
-$30.89 M(+16.1%)
Sep 2015
-
-$8.84 M(+39.4%)
-$26.61 M(+16.5%)
Jun 2015
-
-$6.34 M(+4.6%)
-$22.83 M(+4.2%)
Mar 2015
-
-$6.06 M(+12.9%)
-$21.90 M(+8.9%)
Dec 2014
-$20.12 M(+36.9%)
-$5.37 M(+6.1%)
-$20.12 M(+36.4%)
Sep 2014
-
-$5.06 M(-6.5%)
-$14.75 M(+52.2%)
Jun 2014
-
-$5.41 M(+26.5%)
-$9.69 M(+126.5%)
Mar 2014
-
-$4.28 M
-$4.28 M
Dec 2013
-$14.70 M
-
-

FAQ

  • What is Global Blood Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Global Blood Therapeutics?
  • What is Global Blood Therapeutics annual CFO year-on-year change?
  • What is Global Blood Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Global Blood Therapeutics?
  • What is Global Blood Therapeutics quarterly CFO year-on-year change?
  • What is Global Blood Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Global Blood Therapeutics?
  • What is Global Blood Therapeutics TTM CFO year-on-year change?

What is Global Blood Therapeutics annual cash flow from operations?

The current annual CFO of GBT is -$256.81 M

What is the all time high annual CFO for Global Blood Therapeutics?

Global Blood Therapeutics all-time high annual cash flow from operations is -$14.70 M

What is Global Blood Therapeutics annual CFO year-on-year change?

Over the past year, GBT annual cash flow from operations has changed by -$44.95 M (-21.22%)

What is Global Blood Therapeutics quarterly cash flow from operations?

The current quarterly CFO of GBT is -$44.31 M

What is the all time high quarterly CFO for Global Blood Therapeutics?

Global Blood Therapeutics all-time high quarterly cash flow from operations is -$4.28 M

What is Global Blood Therapeutics quarterly CFO year-on-year change?

Over the past year, GBT quarterly cash flow from operations has changed by +$13.00 K (+0.03%)

What is Global Blood Therapeutics TTM cash flow from operations?

The current TTM CFO of GBT is -$249.40 M

What is the all time high TTM CFO for Global Blood Therapeutics?

Global Blood Therapeutics all-time high TTM cash flow from operations is -$4.28 M

What is Global Blood Therapeutics TTM CFO year-on-year change?

Over the past year, GBT TTM cash flow from operations has changed by -$40.06 M (-19.14%)